Preface |
|
xvii | |
Authors |
|
xix | |
Additional Resources on the Website: Metabolism Online - The Virtual Tutorial |
|
xxi | |
Chapter 1 Why Eat? |
|
1 | (20) |
|
|
1 | (2) |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (2) |
|
1.3.1 The Need for Carbohydrate and Fat |
|
|
5 | (1) |
|
1.3.2 The Need for Protein |
|
|
6 | (1) |
|
1.3.3 The Need for Micronutrients: Minerals and Vitamins |
|
|
6 | (1) |
|
|
6 | (15) |
|
1.4.1 Hunger and Satiety: Short-Term Control of Feeding |
|
|
7 | (3) |
|
1.4.1.1 Nutrient Sensing in the Hypothalamus |
|
|
9 | (1) |
|
1.4.1.2 Ghrelin: The Appetite-Stimulating Hormone |
|
|
9 | (1) |
|
1.4.2 Long-Term Control of Food Intake and Energy Expenditure: The Hormone Leptin |
|
|
10 | (1) |
|
|
11 | (2) |
|
|
11 | (2) |
|
1.4.4 Why Do People Eat What They Do? |
|
|
13 | (4) |
|
1.4.4.1 The Availability and Cost of Food |
|
|
13 | (1) |
|
1.4.4.2 Religion, Habit and Tradition |
|
|
13 | (2) |
|
|
15 | (1) |
|
1.4.4.4 Luxury Status of Scarce and Expensive Foods |
|
|
15 | (1) |
|
1.4.4.5 Social Functions of Food |
|
|
16 | (1) |
|
1.4.4.6 Food Allergy and Intolerance |
|
|
16 | (1) |
|
|
17 | (4) |
|
|
18 | (1) |
|
|
19 | (1) |
|
1.4.5.3 Binge Eating Disorder |
|
|
19 | (1) |
|
1.4.5.4 Other Eating Disorders |
|
|
19 | (2) |
Chapter 2 Enzymes and Metabolic Pathways |
|
21 | (32) |
|
2.1 Chemical Reactions: Breaking and Making Covalent Bonds |
|
|
21 | (3) |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (4) |
|
2.2.1 Specificity of Enzymes |
|
|
26 | (1) |
|
2.2.2 Stages in an Enzyme-Catalyzed Reaction |
|
|
27 | (1) |
|
2.2.3 Units of Enzyme Activity |
|
|
28 | (1) |
|
2.3 Factors Affecting Enzyme Activity |
|
|
28 | (11) |
|
|
28 | (1) |
|
2.3.2 The Effect of Temperature |
|
|
29 | (1) |
|
2.3.3 The Effect of Substrate Concentration |
|
|
30 | (6) |
|
2.3.3.1 Experimental Determination of Km and Vmax |
|
|
33 | (1) |
|
2.3.3.2 Enzymes with Two Substrates |
|
|
34 | (1) |
|
2.3.3.3 Cooperative (Allosteric) Enzymes |
|
|
35 | (1) |
|
2.3.4 Inhibition of Enzyme Activity |
|
|
36 | (3) |
|
2.3.4.1 Irreversible Inhibitors |
|
|
36 | (1) |
|
2.3.4.2 Competitive Reversible Inhibitors |
|
|
36 | (1) |
|
2.3.4.3 Noncompetitive Reversible Inhibitors |
|
|
37 | (2) |
|
2.3.4.4 Uncompetitive Reversible Inhibitors |
|
|
39 | (1) |
|
2.4 Coenzymes and Prosthetic Groups |
|
|
39 | (5) |
|
2.4.1 Coenzymes and Metal Ions in Oxidation and Reduction Reactions |
|
|
40 | (5) |
|
|
41 | (1) |
|
2.4.1.2 Riboflavin and Flavoproteins |
|
|
41 | (1) |
|
2.4.1.3 The Nicotinamide Nucleotide Coenzymes: NAD and NADP |
|
|
42 | (2) |
|
2.5 The Classification and Naming of Enzymes |
|
|
44 | (1) |
|
|
45 | (5) |
|
2.6.1 Linear and Branched Pathways |
|
|
47 | (1) |
|
2.6.2 Spiral or Looped Reaction Sequences |
|
|
47 | (1) |
|
|
47 | (3) |
|
2.7 Enzymes in Clinical Chemistry and Medicine |
|
|
50 | (3) |
|
2.7.1 Measurement of Metabolites in Blood, Urine and Tissue Samples |
|
|
50 | (1) |
|
2.7.2 Measurement of Enzymes in Blood Samples |
|
|
50 | (1) |
|
2.7.3 Assessment of Vitamin Nutritional Status |
|
|
51 | (2) |
Chapter 3 The Role of ATP in Metabolism |
|
53 | (30) |
|
|
53 | (1) |
|
|
54 | (11) |
|
3.2.1 The Role of ATP in Endothermic Reactions |
|
|
55 | (2) |
|
3.2.2 Transport of Materials across Cell Membranes |
|
|
57 | (5) |
|
3.2.2.1 Protein Binding for Concentrative Uptake |
|
|
58 | (1) |
|
3.2.2.2 Metabolic Trapping |
|
|
58 | (1) |
|
|
58 | (1) |
|
3.2.2.4 P-Type Transporters |
|
|
58 | (1) |
|
3.2.2.5 ATP-Binding Cassette (ABC) Transporters |
|
|
58 | (3) |
|
|
61 | (1) |
|
3.2.3 The Role of ATP in Muscle Contraction |
|
|
62 | (3) |
|
3.2.3.1 Creatine Phosphate in Muscle |
|
|
64 | (1) |
|
3.3 Phosphorylation of ADP to ATP |
|
|
65 | (18) |
|
3.3.1 Oxidative Phosphorylation: ATP Synthesis Linked to the Oxidation of Metabolic Fuels |
|
|
65 | (21) |
|
3.3.1.1 The Mitochondrion |
|
|
67 | (2) |
|
3.3.1.2 The Mitochondrial Electron Transport Chain |
|
|
69 | (4) |
|
3.3.1.3 Phosphorylation of ADP Linked to Electron Transport |
|
|
73 | (3) |
|
3.3.1.4 Coupling of Electron Transport, Oxidative Phosphorylation and Fuel Oxidation |
|
|
76 | (1) |
|
|
76 | (1) |
|
3.3.1.6 Respiratory Poisons |
|
|
77 | (6) |
Chapter 4 Digestion and Absorption |
|
83 | (38) |
|
4.1 The Gastrointestinal Tract |
|
|
83 | (3) |
|
4.2 Digestion and Absorption of Carbohydrates |
|
|
86 | (13) |
|
4.2.1 Classification of Carbohydrates |
|
|
87 | (9) |
|
|
88 | (1) |
|
|
89 | (1) |
|
|
90 | (1) |
|
|
91 | (1) |
|
4.2.1.5 Reducing and Nonreducing Sugars |
|
|
92 | (1) |
|
4.2.1.6 Polysaccharides: Starches and Glycogen |
|
|
93 | (1) |
|
|
94 | (2) |
|
4.2.2 Carbohydrate Digestion and Absorption |
|
|
96 | (3) |
|
|
96 | (1) |
|
4.2.2.2 Digestion of Disaccharides |
|
|
97 | (1) |
|
4.2.2.3 Absorption of Monosaccharides |
|
|
98 | (1) |
|
4.3 Digestion and Absorption of Fats |
|
|
99 | (9) |
|
4.3.1 Classification of Dietary Lipids |
|
|
99 | (5) |
|
|
99 | (3) |
|
|
102 | (1) |
|
4.3.1.3 Cholesterol and the Steroids |
|
|
103 | (1) |
|
4.3.2 Digestion and Absorption of Triacylglycerols |
|
|
104 | (4) |
|
|
104 | (2) |
|
4.3.2.2 Lipid Absorption and Chylomicron Formation |
|
|
106 | (2) |
|
4.4 Digestion and Absorption of Proteins |
|
|
108 | (6) |
|
|
109 | (1) |
|
4.4.2 Protein Structure and Denaturation of Proteins |
|
|
109 | (4) |
|
4.4.2.1 Secondary Structure of Proteins |
|
|
109 | (3) |
|
4.4.2.2 Tertiary and Quaternary Structures of Proteins |
|
|
112 | (1) |
|
4.4.2.3 Denaturation of Proteins |
|
|
112 | (1) |
|
|
113 | (1) |
|
4.4.3.1 Activation of Zymogens of Proteolytic Enzymes |
|
|
114 | (1) |
|
4.4.3.2 Absorption of the Products of Protein Digestion |
|
|
114 | (1) |
|
4.5 Absorption of Vitamins and Minerals |
|
|
114 | (7) |
|
4.5.1 Absorption of Lipid-Soluble Vitamins and Cholesterol |
|
|
115 | (1) |
|
4.5.2 Absorption of Water-Soluble Vitamins |
|
|
115 | (1) |
|
4.5.2.1 Absorption of Vitamin B12 |
|
|
116 | (1) |
|
4.5.3 Absorption of Minerals |
|
|
116 | (6) |
|
|
117 | (4) |
Chapter 5 Energy Nutrition: The Metabolism of Carbohydrates and Fats |
|
121 | (52) |
|
5.1 Estimation of Energy Expenditure |
|
|
122 | (7) |
|
5.1.1 Indirect Calorimetry and the Respiratory Quotient (RQ) |
|
|
122 | (1) |
|
5.1.2 Long-Term Measurement of Energy Expenditure: The Dual Isotopically Labeled Water Method |
|
|
123 | (1) |
|
5.1.3 Calculation of Energy Expenditure |
|
|
124 | (6) |
|
5.1.3.1 Basal Metabolic Rate |
|
|
124 | (2) |
|
5.1.3.2 Energy Costs of Physical Activity |
|
|
126 | (1) |
|
5.1.3.3 Diet-Induced Thermogenesis |
|
|
126 | (3) |
|
5.2 Energy Balance and Changes in Body Weight |
|
|
129 | (1) |
|
5.3 Metabolic Fuels in the Fed and Fasting States |
|
|
130 | (4) |
|
|
130 | (2) |
|
|
132 | (2) |
|
5.4 Energy-Yielding Metabolism |
|
|
134 | (15) |
|
5.4.1 Glycolysis: The (Anerobic) Metabolism of Glucose |
|
|
134 | (6) |
|
5.4.1.1 Transfer of NADH Formed during Glycolysis into the Mitochondria |
|
|
137 | (1) |
|
5.4.1.2 Reduction of Pyruvate to Lactate: Anaerobic Glycolysis |
|
|
138 | (2) |
|
5.4.2 The Pentose Phosphate Pathway: An Alternative to Glycolysis |
|
|
140 | (3) |
|
5.4.2.1 The Pentose Phosphate Pathway in Red Blood Cells: Favism |
|
|
140 | (3) |
|
5.4.3 Metabolism of Pyruvate |
|
|
143 | (1) |
|
5.4.3.1 Oxidation of Pyruvate to Acetyl CoA |
|
|
143 | (1) |
|
5.4.4 Oxidation of Acetyl CoA: The Citric Acid Cycle |
|
|
144 | (5) |
|
5.4.4.1 The Citric Acid Cycle as Pathway for Metabolic Interconversion |
|
|
146 | (1) |
|
5.4.4.2 Complete Oxidation of Four- and Five-Carbon Compounds |
|
|
147 | (2) |
|
|
149 | (6) |
|
5.5.1 Carnitine and the Transport of Fatty Acids into the Mitochondrion |
|
|
150 | (2) |
|
5.5.2 β-Oxidation of Fatty Acids |
|
|
152 | (1) |
|
|
153 | (2) |
|
5.6 Tissue Reserves of Metabolic Fuels |
|
|
155 | (14) |
|
5.6.1 Synthesis of Fatty Acids and Triacylglycerols |
|
|
155 | (7) |
|
5.6.1.1 Unsaturated Fatty Acids |
|
|
159 | (1) |
|
5.6.1.2 Synthesis of Triacylglycerol |
|
|
160 | (2) |
|
5.6.2 Plasma Lipoproteins |
|
|
162 | (5) |
|
|
162 | (2) |
|
5.6.2.2 Very Low Density Lipoproteins, Intermediate-Density Lipoproteins and Low-Density Lipoproteins |
|
|
164 | (2) |
|
5.6.2.3 High Density Lipoproteins |
|
|
166 | (1) |
|
|
167 | (8) |
|
5.6.3.1 Glycogen Utilization |
|
|
168 | (1) |
|
5.7 Gluconeogenesis: The Synthesis of Glucose from Noncarbohydrate Precursors |
|
|
169 | (4) |
Chapter 6 Diet and Health: Nutrition and Chronic Noncommunicable Diseases |
|
173 | (50) |
|
6.1 Chronic Noncommunicable Diseases (the "Diseases of Affluence") |
|
|
174 | (1) |
|
6.2 Types of Evidence Linking Diet and Chronic Diseases |
|
|
175 | (5) |
|
6.2.1 Secular Changes in Diet and Disease Incidence |
|
|
175 | (1) |
|
6.2.2 International Correlations between Diet and Disease Incidence |
|
|
176 | (1) |
|
6.2.3 Studies of Migrants |
|
|
177 | (1) |
|
6.2.4 Case-Control Studies |
|
|
178 | (1) |
|
6.2.5 Prospective Studies |
|
|
179 | (1) |
|
6.3 Guidelines for a Prudent Diet |
|
|
180 | (16) |
|
|
184 | (1) |
|
|
184 | (4) |
|
6.3.2.1 The Type of Fat in the Diet |
|
|
184 | (4) |
|
6.3.3 Carbohydrate Intake |
|
|
188 | (4) |
|
6.3.3.1 Sugars in the Diet |
|
|
189 | (1) |
|
6.3.3.2 Undigested Carbohydrates (Dietary Fiber and Non-starch Polysaccharides) |
|
|
190 | (2) |
|
6.3.4 The Gut Microbiome, Diet and Disease |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
194 | (2) |
|
6.4 Nutritional Genomics: Interactions between Diet and Genes |
|
|
196 | (4) |
|
6.4.1 Epigenetic Programming of the Genome |
|
|
197 | (3) |
|
6.4.1.1 Epigenetic Mechanisms |
|
|
197 | (2) |
|
6.4.1.2 Nutritional Epigenetics |
|
|
199 | (1) |
|
6.4.1.3 In Utero and Transgenerational Epigenetic Inheritance |
|
|
199 | (1) |
|
6.5 Free Radicals, Oxidative Damage and Antioxidant Nutrients |
|
|
200 | (9) |
|
6.5.1 Tissue Damage by Oxygen Radicals |
|
|
200 | (2) |
|
6.5.2 Sources of Oxygen Radicals |
|
|
202 | (2) |
|
6.5.2.1 Reoxidation of Reduced Flavin |
|
|
203 | (1) |
|
6.5.2.2 The Macrophage Respiratory Burst |
|
|
203 | (1) |
|
6.5.2.3 Formation of Nitric Oxide |
|
|
203 | (1) |
|
6.5.2.4 Nonenzymic Formation of Radicals |
|
|
203 | (1) |
|
6.5.3 Antioxidant Nutrients and Non-Nutrients: Protection against Radical Damage |
|
|
204 | (5) |
|
6.5.3.1 Superoxide Dismutase, Peroxidases and Catalase |
|
|
205 | (1) |
|
6.5.3.2 Glutathione Peroxidase |
|
|
206 | (1) |
|
6.5.3.3 β-Carotene and Other Carotenes |
|
|
206 | (1) |
|
6.5.3.4 Vitamin C: An Antioxidant and a Prooxidant |
|
|
207 | (1) |
|
6.5.3.5 Intervention Trials with Vitamin E |
|
|
208 | (1) |
|
6.5.3.6 The Antioxidant Paradox |
|
|
208 | (1) |
|
6.6 Homocysteine in Cardiovascular Disease |
|
|
209 | (5) |
|
6.6.1 Factors Affecting Plasma Homocysteine |
|
|
212 | (2) |
|
6.6.1.1 Polymorphisms of Methylene Tetrahydrofolate Reductase |
|
|
212 | (2) |
|
6.6.1.2 Intervention Trials with Folate and Vitamins B6 and B12 |
|
|
214 | (1) |
|
6.7 Other Potentially Protective Compounds in Foods |
|
|
214 | (9) |
|
6.7.1 Inhibition of Cholesterol Absorption or Synthesis |
|
|
215 | (1) |
|
6.7.2 Inhibition of Carcinogen Activation and Increased Conjugation of Activated Metabolites |
|
|
215 | (4) |
|
6.7.2.1 Allyl Sulfur Compounds |
|
|
216 | (1) |
|
|
217 | (1) |
|
|
218 | (1) |
|
|
219 | (1) |
|
6.7.4 Miscellaneous Actions of Phytochemicals |
|
|
220 | (3) |
Chapter 7 Overweight and Obesity |
|
223 | (24) |
|
7.1 Desirable Body Weight |
|
|
223 | (5) |
|
7.1.1 Body Mass Index (BMI) |
|
|
224 | (1) |
|
7.1.2 Estimation of Body Fat |
|
|
225 | (3) |
|
7.1.2.1 Determination of Body Density |
|
|
225 | (1) |
|
7.1.2.2 Determination of Total Body Water or Potassium |
|
|
225 | (2) |
|
7.1.2.3 Imaging Techniques |
|
|
227 | (1) |
|
7.1.2.4 Measurement of Whole Body Electrical Conductivity and Impedance |
|
|
227 | (1) |
|
7.1.2.5 Measurement of Skinfold Thickness |
|
|
228 | (1) |
|
7.2 Problems of Overweight and Obesity |
|
|
228 | (8) |
|
7.2.1 Social Problems of Obesity |
|
|
230 | (1) |
|
7.2.2 Health Risks of Obesity |
|
|
231 | (3) |
|
7.2.2.1 The Distribution of Excess Adipose Tissue |
|
|
232 | (2) |
|
7.2.3 Obesity and the Metabolic Syndrome |
|
|
234 | (2) |
|
7.2.3.1 Insulin Resistance and Hyperinsulinism |
|
|
234 | (1) |
|
|
235 | (1) |
|
|
235 | (1) |
|
|
235 | (1) |
|
7.2.3.5 Macrophage Infiltration of Adipose Tissue |
|
|
236 | (1) |
|
7.2.3.6 Excessive Synthesis of Cortisol |
|
|
236 | (1) |
|
7.3 Causes and Treatment of Obesity |
|
|
236 | (11) |
|
|
236 | (1) |
|
7.3.2 Availability of Food |
|
|
237 | (1) |
|
7.3.3 Control of Appetite |
|
|
238 | (1) |
|
7.3.4 How Obese People Can be Helped to Lose Weight |
|
|
238 | (12) |
|
|
239 | (1) |
|
7.3.4.2 Very Low Energy Diets |
|
|
239 | (1) |
|
7.3.4.3 Conventional Diets |
|
|
239 | (1) |
|
7.3.4.4 Very Low Carbohydrate (Ketogenic) Diets |
|
|
240 | (1) |
|
7.3.4.5 Low Glycemic Index Diets |
|
|
241 | (1) |
|
|
241 | (1) |
|
7.3.4.7 Alternating Food Restriction and Free Consumption |
|
|
242 | (1) |
|
7.3.4.8 "Diets" That Probably Won't Work |
|
|
242 | (1) |
|
|
243 | (1) |
|
7.3.4.10 Sugar Substitutes |
|
|
243 | (1) |
|
|
244 | (1) |
|
7.3.4.12 Pharmacological Treatment of Obesity |
|
|
244 | (1) |
|
7.3.4.13 Surgical Treatment of Obesity |
|
|
245 | (1) |
|
7.3.4.14 Help and Support |
|
|
246 | (1) |
Chapter 8 Protein-Energy Malnutrition: Problems of Undernutrition |
|
247 | (12) |
|
8.1 Problems of Deficiency |
|
|
247 | (3) |
|
8.2 Protein-Energy malnutrition |
|
|
250 | (1) |
|
8.2.1 Detection of Malnutrition in Adults |
|
|
251 | (1) |
|
|
251 | (3) |
|
8.3.1 Causes of Marasmus and Vulnerable Groups of the Population |
|
|
252 | (2) |
|
|
253 | (1) |
|
8.3.1.2 Food Intolerance and Allergy |
|
|
253 | (1) |
|
|
254 | (2) |
|
8.4.1 Hypermetabolism in Cachexia |
|
|
254 | (1) |
|
8.4.2 Increased Protein Catabolism in Cachexia |
|
|
255 | (1) |
|
|
256 | (3) |
|
8.5.1 Factors in the Etiology of Kwashiorkor |
|
|
256 | (1) |
|
8.5.2 Rehabilitation of Malnourished Children |
|
|
257 | (2) |
Chapter 9 Protein Nutrition and Metabolism |
|
259 | (34) |
|
9.1 Nitrogen Balance and Protein Requirements |
|
|
259 | (11) |
|
9.1.1 Dynamic Equilibrium |
|
|
261 | (2) |
|
9.1.1.1 Mechanisms Involved in Tissue Protein Catabolism |
|
|
263 | (1) |
|
9.1.2 Protein Requirements |
|
|
263 | (4) |
|
9.1.2.1 Protein Requirements for Physical Activity and Body Building |
|
|
265 | (1) |
|
9.1.2.2 Protein Requirements of Children |
|
|
266 | (1) |
|
9.1.2.3 Protein Losses in Trauma and Infection: Requirements for Convalescence |
|
|
267 | (1) |
|
9.1.3 Essential Amino Acids |
|
|
267 | (3) |
|
9.1.3.1 Protein Quality and Complementation |
|
|
269 | (1) |
|
9.1.3.2 Unavailable Amino Acids and Protein Digestibility |
|
|
270 | (1) |
|
|
270 | (11) |
|
9.2.1 The Structure and Information Content of DNA |
|
|
270 | (5) |
|
|
273 | (1) |
|
|
273 | (2) |
|
|
275 | (2) |
|
9.2.2.1 Transcription to Form Messenger RNA. |
|
|
276 | (1) |
|
9.2.3 Translation of mRNA: The Process of Protein Synthesis |
|
|
277 | (4) |
|
|
277 | (1) |
|
9.2.3.2 Protein Synthesis on the Ribosome |
|
|
278 | (2) |
|
9.2.3.3 The Energy Cost of Protein Synthesis |
|
|
280 | (1) |
|
9.2.3.4 Posttranslational Modification of Proteins |
|
|
281 | (1) |
|
9.3 Metabolism of Amino Acids |
|
|
281 | (12) |
|
9.3.1 Metabolism of the Amino Nitrogen |
|
|
282 | (8) |
|
|
282 | (1) |
|
|
283 | (2) |
|
9.3.1.3 Metabolism of Ammonia |
|
|
285 | (1) |
|
9.3.1.4 Synthesis of Urea |
|
|
286 | (3) |
|
9.3.1.5 Incorporation of Nitrogen in Biosynthesis |
|
|
289 | (1) |
|
9.3.2 Metabolism of Amino Acid Carbon Skeletons |
|
|
290 | (3) |
Chapter 10 The Integration and Control of Metabolism |
|
293 | (30) |
|
10.1 Patterns of Metabolic Regulation |
|
|
293 | (2) |
|
10.2 Intracellular Regulation of Enzyme Activity |
|
|
295 | (5) |
|
10.2.1 Allosteric Modification of the Activity of Regulatory Enzymes |
|
|
296 | (1) |
|
10.2.2 Control of Glycolysis: The Allosteric Regulation of Phosphofructokinase |
|
|
297 | (3) |
|
10.2.2.1 Feedback Control of Phosphofructokinase |
|
|
298 | (1) |
|
10.2.2.2 Feed-Forward Control of Phosphofructokinase |
|
|
299 | (1) |
|
10.2.2.3 Substrate Cycling |
|
|
300 | (1) |
|
10.3 Responses to Fast-Acting Hormones by Covalent Modification of Enzyme Proteins |
|
|
300 | (8) |
|
10.3.1 Membrane Receptors and G-Proteins |
|
|
302 | (1) |
|
10.3.2 Cyclic AMP and Cyclic GMP as Second Messengers |
|
|
303 | (3) |
|
10.3.2.1 Amplification of the Hormone Signal |
|
|
303 | (3) |
|
10.3.2.2 Desensitization of the Adrenaline Receptor |
|
|
306 | (1) |
|
10.3.3 Inositol Trisphosphate and Diacylglycerol as Second Messengers |
|
|
306 | (2) |
|
10.3.3.1 Amplification of the Hormone Signal |
|
|
307 | (1) |
|
10.3.4 The Insulin Receptor |
|
|
308 | (1) |
|
10.4 Responses to Slow-Acting Signals by Changes in Enzyme Synthesis |
|
|
308 | (4) |
|
10.4.1 Slow-Acting Hormones |
|
|
309 | (2) |
|
10.4.1.1 Amplification of the Hormone Signal |
|
|
311 | (1) |
|
10.4.2 Dietary Control of Enzyme Expression |
|
|
311 | (1) |
|
10.5 Hormonal Control in the Fed and Fasting States |
|
|
312 | (3) |
|
10.5.1 Hormonal Control of Adipose Tissue Metabolism |
|
|
312 | (2) |
|
10.5.2 Control of Lipid Metabolism in the Liver |
|
|
314 | (1) |
|
10.6 Selection of Fuels for Muscle Activity |
|
|
315 | (3) |
|
10.6.1 The Effect of Work Intensity on Muscle Fuel Selection |
|
|
315 | (1) |
|
10.6.2 Muscle Fuel Utilization in the Fed and Fasting States |
|
|
316 | (2) |
|
10.6.2.1 Regulation of Fatty Acid Metabolism in Muscle |
|
|
318 | (1) |
|
10.7 Diabetes Mellitus: A Failure of Regulation of Blood Glucose Concentration |
|
|
318 | (5) |
|
10.7.1 Adverse Effects of Poor Glycemic Control |
|
|
320 | (3) |
Chapter 11 Micronutrients: The Vitamins and Minerals |
|
323 | (98) |
|
11.1 Determination of Requirements and Reference Intakes |
|
|
323 | (10) |
|
11.1.1 Dietary Reference Values |
|
|
324 | (2) |
|
11.1.1.1 Supplements and Safe Levels of Intake |
|
|
326 | (1) |
|
|
326 | (7) |
|
|
333 | (10) |
|
11.2.1 Vitamers and International Units |
|
|
333 | (2) |
|
11.2.2 Metabolism and Storage of Vitamin A and Provitamin A Carotenoids |
|
|
335 | (2) |
|
11.2.2.1 Carotene Dioxygenase |
|
|
335 | (1) |
|
11.2.2.2 Plasma Retinol-Binding Protein |
|
|
336 | (1) |
|
11.2.3 Metabolic Functions of Vitamin A and Carotenes |
|
|
337 | (3) |
|
11.2.3.1 Vitamin A in Vision |
|
|
337 | (1) |
|
11.2.3.2 Retinoic Acid and the Regulation of Gene Expression |
|
|
337 | (3) |
|
11.2.3.3 The Antioxidant Function of Carotenes |
|
|
340 | (1) |
|
11.2.4 Vitamin A Deficiency: Night Blindness and Xerophthalmia |
|
|
340 | (1) |
|
11.2.5 Vitamin A Requirements and Reference Intakes |
|
|
341 | (1) |
|
11.2.5.1 Assessment of Vitamin A Status |
|
|
341 | (1) |
|
11.2.6 Toxicity of Vitamin A |
|
|
341 | (2) |
|
11.2.6.1 Teratogenicity of Vitamin A |
|
|
342 | (1) |
|
11.2.7 Interactions of Vitamin A with Drugs and Other Nutrients |
|
|
343 | (1) |
|
|
343 | (8) |
|
11.3.1 Vitamers and International Units |
|
|
343 | (1) |
|
11.3.2 Absorption and Metabolism of Vitamin D |
|
|
344 | (3) |
|
11.3.2.1 Synthesis of Vitamin D in the Skin |
|
|
344 | (1) |
|
11.3.2.2 Metabolism of Cholecalciferol |
|
|
345 | (1) |
|
11.3.2.3 Regulation of Vitamin D Metabolism |
|
|
345 | (2) |
|
11.3.3 Metabolic Functions of Vitamin D |
|
|
347 | (1) |
|
11.3.4 Vitamin D Deficiency: Rickets and Osteomalacia |
|
|
348 | (1) |
|
11.3.5 Vitamin D Requirements and Reference Intakes |
|
|
349 | (1) |
|
11.3.6 Vitamin D Toxicity |
|
|
350 | (1) |
|
11.3.7 Interactions with Drugs and Other Nutrients |
|
|
351 | (1) |
|
|
351 | (5) |
|
11.4.1 Vitamers and Units of Activity |
|
|
351 | (1) |
|
11.4.2 Absorption and Metabolism of Vitamin E |
|
|
352 | (1) |
|
11.4.3 Metabolic Functions of Vitamin E |
|
|
353 | (1) |
|
11.4.3.1 Non-antioxidant Actions of Vitamin E |
|
|
354 | (1) |
|
11.4.4 Vitamin E Deficiency |
|
|
354 | (1) |
|
11.4.5 Vitamin E Requirements |
|
|
355 | (1) |
|
11.4.5.1 Indices of Vitamin E Status |
|
|
355 | (1) |
|
11.4.5.2 Higher Levels of Intake |
|
|
355 | (1) |
|
11.4.6 Interactions with Other Nutrients |
|
|
355 | (1) |
|
|
356 | (4) |
|
|
356 | (1) |
|
11.5.2 Dietary Sources, Bacterial Synthesis and Metabolism of Vitamin K |
|
|
356 | (1) |
|
11.5.3 Metabolic Functions of Vitamin K |
|
|
357 | (2) |
|
11.5.4 Vitamin K Deficiency and Requirements |
|
|
359 | (1) |
|
11.5.5 Toxicity and Drug Interactions |
|
|
360 | (1) |
|
11.6 Thiamin (Vitamin B1) |
|
|
360 | (4) |
|
11.6.1 Absorption and Metabolism of Thiamin |
|
|
361 | (1) |
|
11.6.2 Metabolic Functions of Thiamin |
|
|
361 | (1) |
|
11.6.3 Thiamin Deficiency |
|
|
362 | (1) |
|
|
362 | (1) |
|
|
363 | (1) |
|
11.6.3.3 Acute Pernicious (Fulminating) Beriberi: Shoshin Beriberi |
|
|
363 | (1) |
|
11.6.3.4 Wernicke-Korsakoff Syndrome |
|
|
363 | (1) |
|
11.6.4 Thiamin Requirements |
|
|
363 | (1) |
|
11.6.5 Assessment of Thiamin Status |
|
|
364 | (1) |
|
11.7 Riboflavin (Vitamin B2) |
|
|
364 | (4) |
|
11.7.1 Absorption and Metabolism of Riboflavin |
|
|
365 | (1) |
|
11.7.1.1 Riboflavin Balance |
|
|
365 | (1) |
|
11.7.2 Metabolic Functions of the Flavin Coenzymes |
|
|
366 | (1) |
|
11.7.2.1 Flavin and Oxidative Stress |
|
|
366 | (1) |
|
11.7.3 Riboflavin Deficiency |
|
|
366 | (1) |
|
11.7.3.1 Resistance to Malaria in Riboflavin Deficiency |
|
|
367 | (1) |
|
11.7.4 Riboflavin Requirements |
|
|
367 | (1) |
|
11.7.5 Assessment of Riboflavin Nutritional Status |
|
|
367 | (1) |
|
11.7.6 Interactions with Drugs and Other Nutrients |
|
|
368 | (1) |
|
|
368 | (7) |
|
11.8.1 Vitamers and Niacin Equivalents |
|
|
368 | (2) |
|
11.8.1.1 Unavailable Niacin in Cereals |
|
|
370 | (1) |
|
11.8.2 Absorption and Metabolism of Niacin |
|
|
370 | (2) |
|
11.8.2.1 Catabolism of NAD(P) |
|
|
372 | (1) |
|
11.8.2.2 Urinary Excretion of Niacin and Metabolites |
|
|
372 | (1) |
|
11.8.3 Metabolic Functions of Niacin |
|
|
372 | (1) |
|
11.8.4 Pellagra: A Disease of Tryptophan and Niacin Deficiency |
|
|
373 | (1) |
|
11.8.4.1 Additional Factors in the Etiology of Pellagra |
|
|
374 | (1) |
|
11.8.5 Niacin Requirements |
|
|
374 | (1) |
|
11.8.6 Assessment of Niacin Status |
|
|
374 | (1) |
|
|
374 | (1) |
|
|
375 | (5) |
|
|
375 | (1) |
|
11.9.2 Absorption and Metabolism of Vitamin B6 |
|
|
375 | (1) |
|
11.9.3 Metabolic Functions of Vitamin B6 |
|
|
376 | (1) |
|
11.9.4 Vitamin B6 Deficiency |
|
|
377 | (1) |
|
11.9.5 Vitamin B6 Requirements |
|
|
377 | (1) |
|
11.9.5.1 Requirements of Infants |
|
|
378 | (1) |
|
11.9.6 Assessment of Vitamin B6 Status |
|
|
378 | (1) |
|
11.9.6.1 Coenzyme Saturation of Transaminases |
|
|
378 | (1) |
|
11.9.6.2 The Tryptophan Load Test |
|
|
379 | (1) |
|
11.9.6.3 The Methionine Load Test |
|
|
379 | (1) |
|
11.9.7 Non-nutritional Uses of Vitamin B6 |
|
|
379 | (1) |
|
11.9.8 Vitamin B6 Toxicity |
|
|
380 | (1) |
|
|
380 | (5) |
|
11.10.1 Structure and Vitamers |
|
|
380 | (2) |
|
11.10.2 Absorption and Metabolism of Vitamin B12 |
|
|
382 | (1) |
|
11.10.2.1 Enterohepatic Circulation of Vitamin B12 |
|
|
382 | (1) |
|
11.10.3 Metabolic Functions of Vitamin B12 |
|
|
383 | (1) |
|
11.10.4 Vitamin B12 Deficiency: Pernicious Anemia |
|
|
383 | (1) |
|
11.10.4.1 Drug-Induced Vitamin B12 Deficiency |
|
|
383 | (1) |
|
11.10.5 Vitamin B12 Requirements |
|
|
384 | (1) |
|
11.10.6 Assessment of Vitamin B12 Status |
|
|
384 | (1) |
|
11.10.6.1 The Schilling Test for Vitamin B12 Absorption |
|
|
384 | (1) |
|
11.10.6.2 Methylmalonic Aciduria |
|
|
384 | (1) |
|
11.11 Folic Acid and the Folates |
|
|
385 | (9) |
|
11.11.1 Vitamers and Dietary Equivalence |
|
|
385 | (1) |
|
11.11.2 Absorption and Metabolism of Folate |
|
|
386 | (1) |
|
11.11.2.1 Tissue Uptake of Folate |
|
|
387 | (1) |
|
11.11.2.2 Folate Excretion |
|
|
387 | (1) |
|
11.11.3 Metabolic Functions of Folate |
|
|
387 | (4) |
|
11.11.3.1 Thymidylate Synthetase and Dihydrofolate Reductase |
|
|
388 | (1) |
|
11.11.3.2 Methionine Synthetase and the Methyl-Folate Trap |
|
|
389 | (1) |
|
11.11.3.3 Methylene-Tetrahydrofolate Reductase and Hyperhomocysteinemia |
|
|
390 | (1) |
|
11.11.3.4 Folate in Pregnancy |
|
|
390 | (1) |
|
11.11.3.5 Folate and Cancer |
|
|
391 | (1) |
|
11.11.4 Folate Deficiency: Megaloblastic Anemia |
|
|
391 | (1) |
|
11.11.5 Folate Requirements |
|
|
392 | (1) |
|
11.11.6 Assessment of Folate Status |
|
|
392 | (1) |
|
11.11.6.1 Histidine Metabolism: The Formiminoglutamate (FIGLU) Test |
|
|
392 | (1) |
|
11.11.6.2 The dUMP Suppression Test |
|
|
392 | (1) |
|
11.11.7 Drug-Nutrient Interactions of Folate |
|
|
393 | (1) |
|
|
393 | (1) |
|
|
394 | (2) |
|
11.12.1 Absorption and Metabolism of Biotin |
|
|
394 | (1) |
|
11.12.2 Metabolic Functions of Biotin |
|
|
395 | (1) |
|
11.12.3 Biotin Deficiency and Requirements |
|
|
395 | (1) |
|
11.12.3.1 Glucose Metabolism in Biotin Deficiency |
|
|
396 | (1) |
|
11.12.3.2 Lipid Metabolism in Biotin Deficiency |
|
|
396 | (1) |
|
11.12.4 Safe and Adequate Levels of Intake |
|
|
396 | (1) |
|
|
396 | (2) |
|
11.13.1 Absorption, Metabolism and Metabolic Functions of Pantothenic Acid |
|
|
397 | (1) |
|
11.13.1.1 Coenzyme A and Acyl Carrier Protein |
|
|
397 | (1) |
|
11.13.2 Pantothenic Acid Deficiency and Safe and Adequate Levels of Intake |
|
|
397 | (1) |
|
11.13.3 Nonnutritional Uses of Pantothenic Acid |
|
|
398 | (1) |
|
11.14 Vitamin C (Ascorbic Acid) |
|
|
398 | (7) |
|
11.14.1 Absorption and Metabolism of Vitamin C |
|
|
399 | (1) |
|
11.14.2 Metabolic Functions of Vitamin C |
|
|
400 | (1) |
|
11.14.2.1 Copper-Containing Hydroxylases |
|
|
400 | (1) |
|
11.14.2.2 Oxoglutarate-Linked Iron-Containing Hydroxylases |
|
|
400 | (1) |
|
11.14.2.3 Prooxidant and Antioxidant Roles of Ascorbate |
|
|
401 | (1) |
|
11.14.3 Vitamin C Deficiency: Scurvy |
|
|
401 | (1) |
|
11.14.3.1 Anemia in Scurvy |
|
|
402 | (1) |
|
11.14.4 Vitamin C Requirements |
|
|
402 | (1) |
|
11.14.5 Assessment of Vitamin C Status |
|
|
403 | (1) |
|
11.14.6 Possible Benefits of High Intakes of Vitamin C |
|
|
404 | (1) |
|
11.14.6.1 Iron Absorption |
|
|
404 | (1) |
|
11.14.6.2 Inhibition of Nitrosamine Formation |
|
|
404 | (1) |
|
11.14.6.3 Pharmacological Uses of Vitamin C |
|
|
405 | (1) |
|
11.14.7 Toxicity of Vitamin C |
|
|
405 | (1) |
|
|
405 | (2) |
|
|
405 | (1) |
|
|
406 | (1) |
|
|
406 | (1) |
|
|
407 | (1) |
|
11.15.5 Ubiquinone (Coenzyme Q, "Vitamin Q") |
|
|
407 | (1) |
|
|
407 | (14) |
|
|
408 | (4) |
|
11.16.1.1 Calcium Homeostasis |
|
|
409 | (2) |
|
|
411 | (1) |
|
11.16.2 Minerals That Function as Prosthetic Groups in Enzymes |
|
|
412 | (3) |
|
|
412 | (1) |
|
|
412 | (1) |
|
|
412 | (1) |
|
|
413 | (1) |
|
|
413 | (1) |
|
|
414 | (1) |
|
11.16.3 Minerals That Have a Regulatory Role (in Neurotransmission, as Enzyme Activators or in Hormones) |
|
|
415 | (2) |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
416 | (1) |
|
|
416 | (1) |
|
11.16.3.6 Sodium and Potassium |
|
|
417 | (1) |
|
11.16.4 Minerals Known to Be Essential, but Whose Function Is not Known |
|
|
417 | (1) |
|
|
417 | (1) |
|
|
417 | (1) |
|
|
417 | (1) |
|
11.16.5 Minerals That Have Effects in the Body, but Whose Essentiality Is Not Established |
|
|
417 | (1) |
|
|
417 | (1) |
|
|
418 | (1) |
|
|
418 | (1) |
|
11.17 Nutritional Anemias |
|
|
418 | (3) |
Index |
|
421 | |